Antiarrhythmic drugs | Search Results | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Search Results for 'Antiarrhythmic drugs'

@ClevelandClinic – Cardiac Consult: Catheter Ablation vs Antiarrhythmic Drug Therapy in Atrial Fibrillation: CABANA – What Did We Learn?

Posted in Ablation Procedure vs Drug Therapy, Frontiers in Cardiology and Cardiovascular Disorders on May 26, 2019| Leave a Comment »

@ClevelandClinic – Cardiac Consult: Catheter Ablation vs Antiarrhythmic Drug Therapy in Atrial Fibrillation: CABANA – What Did We Learn? Reporter: Aviva Lev-Ari, PhD, RN AUDIT PODCAST https://my.clevelandclinic.org/podcasts/cardiac-consult/catheter-ablation-vs-antiarrhythmic-drug-therapy-in-atrial-fibrillation-cabana?_ga=2.88658141.711601484.1558922695-amp-RRJ7UwWd4zu5JL6IeLrcYA The international CABANA trial (Catheter Ablation versus Arrhythmia Drug Therapy for Atrial Fibrillation) was the biggest buzz at the Heart Rhythm Society Scientific Sessions earlier this year, […]

Read Full Post »

Antiarrhythmic Drug Therapy: Calcium Antagonists and Beta-Adrenergic Blockers

Posted in Ca2+ triggered activation, Calcium Signaling, Cardiovascular Research, Curation, Electrophysiology, Pharmaceutical Analytics, Pharmaceutical Drug Discovery, Pharmacologic toxicities, Signaling, Signaling & Cell Circuits, Translational Science on February 21, 2016| Leave a Comment »

There are three calcium-channel blocking drugs available, but only verapamil possesses significant clinical antiarrhythmic effects. Since the drug affects Sourced through Scoop.it from: my-medstore-canada.net See on Scoop.it – Cardiovascular Disease: PHARMACO-THERAPY

Read Full Post »

Effectiveness of Anti-arrhythmic Drugs: Amiodarone and Lidocaine, for treating sudden cardiac arrest, increasing likelihood of Patients Surviving Emergency Transport to Hospital

Posted in Cardiovascular Research, Electrophysiology, Frontiers in Cardiology and Cardiovascular Disorders, Origins of Cardiovascular Disease, Pharmacotherapy of Cardiovascular Disease, tagged Amiodarone, Cardiac Arrest, lidocaine, ventricular fibrillation and ventricular tachycardia on April 4, 2016| Leave a Comment »

Effectiveness of Anti-arrhythmic Drugs: Amiodarone and Lidocaine, for treating sudden cardiac arrest, increasing likelihood of Patients Surviving Emergency Transport to Hospital Curator: Aviva Lev-Ari, PhD, RN Original Study http://www.nejm.org/doi/full/10.1056/NEJMoa1514204 Editorial Out-of-Hospital Cardiac Arrest — Are Drugs Ever the Answer? Jose A. Joglar, M.D., and Richard L. Page, M.D. http://www.nejm.org/doi/pdf/10.1056/NEJMe1602790 Monday, April 4, 2016 Antiarrhythmic […]

Read Full Post »

What Are Your Medication Options for Heart Arrhythmias?

Posted in Ablation Procedure vs Drug Therapy, Arrhythmia Detection with Machine Learning Algorithms, Electrophysiology, Frontiers in Cardiology and Cardiovascular Disorders, Pharmacotherapy of Cardiovascular Disease on January 9, 2016| Leave a Comment »

What Are Your Medication Options for Heart Arrhythmias? Reporter: Aviva Lev-Ari, PhD, RN Heart arrhythmias can be treated with antiarrhythmic drugs, AV nodal blocking drugs, beta blockers, statins, and omega-3 fatty acids. Sourced through Scoop.it from: heartdisease.about.com See on Scoop.it – Cardiovascular Disease: PHARMACO-THERAPY See our Book Original Volume Five: Pharmacological Agents in Treatment of […]

Read Full Post »

Warfarin and Dabigatran, Similarities and Differences

Posted in Acute Myocardial Infarction, Bio Instrumentation in Experimental Life Sciences Research, Cardiovascular Research, Coagulation Therapy and Internal Bleeding, Frontiers in Cardiology and Cardiovascular Disorders, Health Economics and Outcomes Research, Origins of Cardiovascular Disease, Peripheral Arterial Disease & Peripheral Vascular Surgery, Personalized and Precision Medicine & Genomic Research, Pharmacotherapy of Cardiovascular Disease, Spontaneous Coronary Artery Dissection (SCAD), Statistical Methods for Research Evaluation, tagged anti thrumbus, anticoagulants, clot, Coagulation, PDA on April 4, 2016| Leave a Comment »

Warfarin and Dabigatran, Similarities and Differences Author and Curator: Danut Dragoi, PhD What anticoagulants do? An anticoagulant helps your body control how fast your blood clots; therefore, it prevents clots from forming inside your arteries, veins or heart during certain medical conditions. If you have a blood clot, an anticoagulant may prevent the clot […]

Read Full Post »

Ischemia-Related Subcellular Redistribution of Sodium Channels Enhances the Proarrhythmic Effect of Class I Antiarrhythmic Drugs: A Simulation Study

Posted in Electrophysiology, Frontiers in Cardiology and Cardiovascular Disorders, Na +, Pharmacotherapy of Cardiovascular Disease on October 10, 2014| Leave a Comment »

Ischemia-Related Subcellular Redistribution of Sodium Channels Enhances the Proarrhythmic Effect of Class I Antiarrhythmic Drugs: A Simulation Study Reporter: Aviva Lev-Ari, PhD, RN PLOS ONE: an inclusive, peer-reviewed, open-access resource from the PUBLIC LIBRARY OF SCIENCE. Reports of well-performed scientific studies from all disciplines freely available […]

Read Full Post »

Antiarrhythmic drug therapy increases hospitalisation risk for older patients with atrial fibrillation and coronary artery disease

Posted in Uncategorized on April 27, 2014| Leave a Comment »

See on Scoop.it – Cardiovascular Disease: PHARMACO-THERAPY A single centre analysis of antiarrhythmic drug therapy in older patients with atrial fibrillation and coronary artery disease has found it is associated with increased rehospitalisation at one year, and recommends safer and more effective therapies for symptom control in this group. See on http://www.cxvascular.com

Read Full Post »

Atrial Fibrillation and Silent Cerebral Infarctions: A Meta Analysis Study and Literature Review

Posted in Electrophysiology, Frontiers in Cardiology and Cardiovascular Disorders, Origins of Cardiovascular Disease on November 4, 2014| Leave a Comment »

Atrial Fibrillation and Silent Cerebral Infarctions: A Meta Analysis Study and Literature Review Reporter: Aviva Lev-Ari, PhD, RN UPDATED on 5/26/2019 @ClevelandClinic – Cardiac Consult: Catheter Ablation vs Antiarrhythmic Drug Therapy in Atrial Fibrillation: CABANA – What Did We Learn? Reporter: Aviva Lev-Ari, PhD, RN https://pharmaceuticalintelligence.com/2019/05/26/clevelandclinic-cardiac-consult-catheter-ablation-vs-antiarrhythmic-drug-therapy-in-atrial-fibrillation-cabana-what-did-we-learn/ Conclusion: Atrial fibrillation is associated with more than […]

Read Full Post »

Calcium Channel Blocker Potential for Angina

Posted in Acute Myocardial Infarction, Biological Networks, Ca2+ triggered activation, Calcium Signaling, Cardiomyopathy, Cardiovascular Research, Cell Biology, Signaling & Cell Circuits, Chemical Biology and its relations to Metabolic Disease, Clinical & Translational, Curation, Disease Biology, Small Molecules in Development of Therapeutic Drugs, FDA, CE Mark & Global Regulatory Affairs: process management and strategic planning - GCP, GLP, ISO 14155, Frontiers in Cardiology and Cardiovascular Disorders, Gene Regulation, HTN, Myocardial metabolism, Myocardial ischemia, myocardial perfusion, Myocardial adenine nucleotide metabolism, Pharmacotherapy of Cardiovascular Disease, tagged angina, calcium channels, Hypertension, pharmacotherapy on December 11, 2015| Leave a Comment »

Calcium Channel Blocker Potential for Angina Larry H. Bernstein, MD, FCAP, Curator LPBI Pranidipine ANTHONY MELVIN CRASTO, PhD https://newdrugapprovals.files.wordpress.com/2015/12/str116.jpg Pranidipine , OPC-13340, FRC 8411 Acalas® NDA Filing in Japan A calcium channel blocker potentially for the treatment of angina pectoris and hypertension. CAS No. 99522-79-9 Molecular FormulaC25H24N2O6 Average mass 448.468 […]